No Data
No Data
MediWound and Vericel Win FDA Paediatric Label Expansion for NexoBrid
MediWound Gets FDA Approval for Severe Thermal Burn Treatment for Pediatric Patients
Express News | MediWound NexoBrid For Treatment Pediatric Patients With Severe Thermal Burns Approved By FDA
Express News | Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
MediWound Analyst Ratings
H.C. Wainwright Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $28
No Data